GlassScriptPhysician profile
Veronica Francisca Lopez
NPI 1225294259
$7,709.53
in general payments reported to CMS, 2019-2025
7 companies · $5,780 in 2025
The $5,780 reported for 2025 was more than what 99% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.95 · 2020: $105 · 2022: $1,501 · 2023: $190 · 2024: $41.50 · 2025: $5,780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,600 · Food and Beverage: $261 · Travel and Lodging: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,600.00 |
| Food and Beverage | $261.26 |
| Travel and Lodging | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $5,750.00 | 2025 | |
| Zimvie INC. | $1,666.56 | 2022-2024 | |
| Gilead Sciences, INC. | $130.79 | 2019-2023 | Descovy |
| Align Technology, INC. | $119.86 | 2020-2025 | Invisalign |
| Orapharma, A Division of Bausch Health US, LLC | $15.00 | 2020 | |
| Philips North America LLC | $14.25 | 2023 | |
| Voco America INC. | $13.07 | 2023 | Admira Fusion X-Tra, Futurabond U, Voco Profluorid Varnish |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.